FDA approves HIV drug for use in adults with resistance to existing treatments.
Isentress, by Merck & Co., is the first of new class of drugs to get approval.
More testing necessary before it is approved for new HIV patients, children.
Drug works by blocking different enzymes involved in HIV replication.
